401 related articles for article (PubMed ID: 35672862)
21. Targeting macrophages for enhancing CD47 blockade-elicited lymphoma clearance and overcoming tumor-induced immunosuppression.
Cao X; Wang Y; Zhang W; Zhong X; Gunes EG; Dang J; Wang J; Epstein AL; Querfeld C; Sun Z; Rosen ST; Feng M
Blood; 2022 Jun; 139(22):3290-3302. PubMed ID: 35134139
[TBL] [Abstract][Full Text] [Related]
22. Targeted delivery of ibrutinib to tumor-associated macrophages by sialic acid-stearic acid conjugate modified nanocomplexes for cancer immunotherapy.
Qiu Q; Li C; Song Y; Shi T; Luo X; Zhang H; Hu L; Yan X; Zheng H; Liu M; Liu M; Liu M; Yang S; Liu X; Chen G; Deng Y
Acta Biomater; 2019 Jul; 92():184-195. PubMed ID: 31108259
[TBL] [Abstract][Full Text] [Related]
23. Tumor-Associated Macrophages: Reasons to Be Cheerful, Reasons to Be Fearful.
Szulc-Kielbik I; Kielbik M
Exp Suppl; 2022; 113():107-140. PubMed ID: 35165862
[TBL] [Abstract][Full Text] [Related]
24. Nanomaterials targeting tumor associated macrophages for cancer immunotherapy.
Zhao C; Pang X; Yang Z; Wang S; Deng H; Chen X
J Control Release; 2022 Jan; 341():272-284. PubMed ID: 34813877
[TBL] [Abstract][Full Text] [Related]
25. New insights into the role of macrophages in cancer immunotherapy.
Zhou L; Zhao T; Zhang R; Chen C; Li J
Front Immunol; 2024; 15():1381225. PubMed ID: 38605951
[TBL] [Abstract][Full Text] [Related]
26. The Role of Macrophages in Cancer Development and Therapy.
Cendrowicz E; Sas Z; Bremer E; Rygiel TP
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33919517
[TBL] [Abstract][Full Text] [Related]
27. Macrophage-modulating nanomedicine for cancer immunotherapy.
Khan MM; Li Y; Zhou Z; Ni A; Saiding Q; Qin D; Tao W; Chen W
Nanoscale; 2024 Apr; 16(15):7378-7386. PubMed ID: 38511468
[TBL] [Abstract][Full Text] [Related]
28. Tumor-Associated Macrophages Regulate PD-1/PD-L1 Immunosuppression.
Pu Y; Ji Q
Front Immunol; 2022; 13():874589. PubMed ID: 35592338
[TBL] [Abstract][Full Text] [Related]
29. A narrative review of tumor-associated macrophages in lung cancer: regulation of macrophage polarization and therapeutic implications.
Sedighzadeh SS; Khoshbin AP; Razi S; Keshavarz-Fathi M; Rezaei N
Transl Lung Cancer Res; 2021 Apr; 10(4):1889-1916. PubMed ID: 34012800
[TBL] [Abstract][Full Text] [Related]
30. Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy.
Li M; Li M; Yang Y; Liu Y; Xie H; Yu Q; Tian L; Tang X; Ren K; Li J; Zhang Z; He Q
J Control Release; 2020 May; 321():23-35. PubMed ID: 32035193
[TBL] [Abstract][Full Text] [Related]
31. Blocking Triggering Receptor Expressed on Myeloid Cells-1-Positive Tumor-Associated Macrophages Induced by Hypoxia Reverses Immunosuppression and Anti-Programmed Cell Death Ligand 1 Resistance in Liver Cancer.
Wu Q; Zhou W; Yin S; Zhou Y; Chen T; Qian J; Su R; Hong L; Lu H; Zhang F; Xie H; Zhou L; Zheng S
Hepatology; 2019 Jul; 70(1):198-214. PubMed ID: 30810243
[TBL] [Abstract][Full Text] [Related]
32. Tailoring Nanomaterials for Targeting Tumor-Associated Macrophages.
Ovais M; Guo M; Chen C
Adv Mater; 2019 May; 31(19):e1808303. PubMed ID: 30883982
[TBL] [Abstract][Full Text] [Related]
33. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
[TBL] [Abstract][Full Text] [Related]
34. Tumor-associated macrophages as major players in the tumor microenvironment.
Chanmee T; Ontong P; Konno K; Itano N
Cancers (Basel); 2014 Aug; 6(3):1670-90. PubMed ID: 25125485
[TBL] [Abstract][Full Text] [Related]
35. Cancer Immunotherapy: Targeting Tumor-Associated Macrophages by Gene Silencing.
Zins K; Abraham D
Methods Mol Biol; 2020; 2115():289-325. PubMed ID: 32006408
[TBL] [Abstract][Full Text] [Related]
36. Targeting Tumor-Associated Macrophages in Anti-Cancer Therapies: Convincing the Traitors to Do the Right Thing.
Belgiovine C; Digifico E; Anfray C; Ummarino A; Torres Andón F
J Clin Med; 2020 Oct; 9(10):. PubMed ID: 33050070
[TBL] [Abstract][Full Text] [Related]
37. Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival.
Cieslewicz M; Tang J; Yu JL; Cao H; Zavaljevski M; Motoyama K; Lieber A; Raines EW; Pun SH
Proc Natl Acad Sci U S A; 2013 Oct; 110(40):15919-24. PubMed ID: 24046373
[TBL] [Abstract][Full Text] [Related]
38. Tumor promoting role of anti-tumor macrophages in tumor microenvironment.
Goswami KK; Ghosh T; Ghosh S; Sarkar M; Bose A; Baral R
Cell Immunol; 2017 Jun; 316():1-10. PubMed ID: 28433198
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic potential of anti-VEGF receptor 2 therapy targeting for M2-tumor-associated macrophages in colorectal cancer.
Min AKT; Mimura K; Nakajima S; Okayama H; Saito K; Sakamoto W; Fujita S; Endo H; Saito M; Saze Z; Momma T; Ohki S; Kono K
Cancer Immunol Immunother; 2021 Feb; 70(2):289-298. PubMed ID: 32705303
[TBL] [Abstract][Full Text] [Related]
40. Reprogramming of tumor-associated macrophages by metabolites generated from tumor microenvironment.
Kim SW; Kim CW; Moon YA; Kim HS
Anim Cells Syst (Seoul); 2024; 28(1):123-136. PubMed ID: 38577621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
